Target intelligence / Profile preview

MLLT10 pseudogene 2 (MLLT10P2)

Target
MLLT10P2
Molecular classification
Other (Pseudogene)
01

Overview

MLLT10 pseudogene 2 (MLLT10P2) is a genomic pseudogene, which means it is a non-functional copy derived from the MLLT10 gene[1]. Unlike MLLT10, which encodes a protein cofactor for DOT1L and plays roles in transcriptional regulation and chromatin modification associated with leukemias[3][5][9], MLLT10P2 does not produce a protein or perform biological functions. Pseudogenes are widely distributed in the genome and generally do not serve as direct drug targets or receptors. The biological and therapeutic relevance of MLLT10P2 is minimal; it is primarily of interest for genomic annotation rather than medicinal or pharmacological purposes[1]. For genuine therapeutic targets related to this family, refer to the functional MLLT10 gene and protein, sometimes called AF10, which participates in transcriptional and chromatin-remodeling complexes with roles in acute myeloid leukemia and other cancers[3][5][9].

Other names
MLLT10P2Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 pseudogene 2

Beyond the preview

Go deeper on MLLT10 pseudogene 2 (MLLT10P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MLLT10 pseudogene 2 (MLLT10P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call